Cue Biopharma, Inc. ( CUE) - Stock Earnings
CUE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
CUE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.6 million USD | 21.9 million USD |
| 2026Q1 | -5.2 million USD | 5.7 million USD |
| 2026Q2 | -153.1 million USD | 7.9 million USD |
| 2026Q4 Est. | — | — |
CUE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -50.7 million USD | 5.5 million USD |
| 2024 | -40.7 million USD | 9.3 million USD |
| 2025 | -26.6 million USD | 27.5 million USD |
| 2026 Est. | — | — |
CUE
Price: $18.67
52 week price:
Earnings Per Share: -28.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 255300
Market Capitalization: 168.1 million